Buprenorphine and Integrated HIV Care Evaluation - Related Studies

Buprenorphine and Integrated HIV Care Evaluation

This study is currently recruiting participants.

Study NCT00124358. Last updated on March 23, 2007. Information provided by The New York Academy of Medicine

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Opioid-Related Disorders
		HIV Infections
		AIDS

2	Additional conditions recognized in this trial
		Acquired Immunodeficiency Syndrome
		Infection

3	More general conditions related to this trial
		Disorders of Environmental Origin
		Immune System Diseases
		Immunologic Deficiency Syndromes
		Lentivirus Infections
		Mental Disorders
		Retroviridae Infections
		RNA Virus Infections
		Sexually Transmitted Diseases
		Sexually Transmitted Diseases, Viral
		Slow Virus Diseases
		Substance-Related Disorders
		Virus Diseases

4	Interventions listed in this trial
		Buprenorphine

5	More general drug interventions related to this trial
		Analgesics
		Analgesics, Opioid
		Central Nervous System Agents
		Central Nervous System Depressants
		Narcotic Antagonists
		Narcotics
		Peripheral Nervous System Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Sensory System Agents
		Therapeutic Uses

6	Sponsors listed in this trial
		The New York Academy of Medicine
		Health Resources &Services Administration
		El Rio Santa Cruz Neighborhood Health Center
		Organization to Achieve Solutions in Substance Abuse (OASIS)
		Oregon Health and Science University
		Montefiore Medical Center
		University of Miami
		Brown University
		University of California, San Francisco
		Johns Hopkins University
		CORE Center, Cook County Bureau of Health Services
		Yale University